PART I NeoGenomics, Inc., a Nevada corporation (referred to individually as the Company or collectively with its subsidiaries as NeoGenomics, we, us, or our in this Annual Report on Form 10-K) is the registrant for SEC reporting purposes. Our common stock is listed on The Nasdaq Stock Market LLC (Nasdaq) under the symbol NEO. Overview NeoGenomics provides a wide range of oncology diagnostic testing and consultative services including technical laboratory services and professional interpretation ...
Q2 FY2026 — expected 2026-08-21
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-17 | 2025-12-31 | 0001077183-26-000010 | EDGAR | 67K words |
| 2025-02-18 | 2024-12-31 | 0001077183-25-000028 | EDGAR | — |
| 2024-02-20 | 2023-12-31 | 0001077183-24-000011 | EDGAR | — |
| 2023-02-24 | 2022-12-31 | 0001077183-23-000023 | EDGAR | — |
| 2022-02-25 | 2021-12-31 | 0001077183-22-000017 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0001077183-21-000064 | EDGAR | — |
| 2020-02-28 | 2019-12-31 | 0001077183-20-000022 | EDGAR | — |
| 2019-02-26 | 2018-12-31 | 0001077183-19-000008 | EDGAR | — |
| 2018-03-13 | 2017-12-31 | 0001564590-18-005479 | EDGAR | — |
| 2017-03-14 | 2016-12-31 | 0001564590-17-004158 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-10-28 | 2025-09-30 | 0001077183-25-000175 | EDGAR | 23K words |
| 2025-07-29 | 2025-06-30 | 0001077183-25-000154 | EDGAR | — |
| 2025-04-29 | 2025-03-31 | 0001077183-25-000076 | EDGAR | — |
| 2024-11-05 | 2024-09-30 | 0001077183-24-000157 | EDGAR | — |
| 2024-07-30 | 2024-06-30 | 0001077183-24-000109 | EDGAR | — |
| 2024-04-30 | 2024-03-31 | 0001077183-24-000054 | EDGAR | — |
| 2023-11-06 | 2023-09-30 | 0001077183-23-000138 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0001077183-23-000103 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001077183-23-000042 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001077183-22-000173 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001077183-22-000135 | EDGAR | — |
| 2022-05-09 | 2022-03-31 | 0001077183-22-000081 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-17 | 0001077183-26-000004 | EDGAR | 8K words |
| 2026-01-12 | 0001628280-26-001746 | EDGAR | — |
| 2025-12-30 | 0001628280-25-059067 | EDGAR | — |
| 2025-10-28 | 0001077183-25-000172 | EDGAR | — |
| 2025-08-08 | 0001077183-25-000162 | EDGAR | — |
| 2025-07-29 | 0001077183-25-000151 | EDGAR | — |
| 2025-06-24 | 0001077183-25-000145 | EDGAR | — |
| 2025-05-27 | 0001077183-25-000109 | EDGAR | — |
| 2025-04-29 | 0001077183-25-000074 | EDGAR | — |
| 2025-04-08 | 0001077183-25-000067 | EDGAR | — |
300 total filings indexed. 268 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001077183 |
| Ticker | NEO |
| Exchange | Nasdaq |
| SIC | 8734: Services-Testing Laboratories |
| Incorporated | NV |
| Website | https://www.neogenomics.com |
| Listed | 1996-01-25 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report